Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial

Objective To examine the effect on adherence to disease modifying anti-rheumatic drugs (DMARDs) in participants with rheumatoid arthritis (RA) of a serious game that targeted implicit attitudes toward medication.Methods A multicentre randomised controlled trial (RCT) was performed with adults with R...

Full description

Bibliographic Details
Main Authors: Sandra van Dulmen, Johanna E Vriezekolk, Bart van den Bemt, Harald E Vonkeman, Renske CF Hebing, Bart P H Pouls, Charlotte L Bekker, Fatma Gundogan, Hein AW van Onzenoort, Liesbeth I van de Ven, Rob Tieben
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002616.full
_version_ 1811189172034076672
author Sandra van Dulmen
Johanna E Vriezekolk
Bart van den Bemt
Harald E Vonkeman
Renske CF Hebing
Bart P H Pouls
Charlotte L Bekker
Fatma Gundogan
Hein AW van Onzenoort
Liesbeth I van de Ven
Rob Tieben
author_facet Sandra van Dulmen
Johanna E Vriezekolk
Bart van den Bemt
Harald E Vonkeman
Renske CF Hebing
Bart P H Pouls
Charlotte L Bekker
Fatma Gundogan
Hein AW van Onzenoort
Liesbeth I van de Ven
Rob Tieben
author_sort Sandra van Dulmen
collection DOAJ
description Objective To examine the effect on adherence to disease modifying anti-rheumatic drugs (DMARDs) in participants with rheumatoid arthritis (RA) of a serious game that targeted implicit attitudes toward medication.Methods A multicentre randomised controlled trial (RCT) was performed with adults with RA that used DMARDs and possessed a smartphone/tablet. Control and intervention groups received care as usual. The intervention group played the serious game at will during 3 months. Game play data and online questionnaires Compliance Questionnaire on Rheumatology (CQR), Beliefs about Medicine Questionnaire (BMQ), Health Assessment Questionnaire (HAQ) and Rheumatoid Arthritis Disease Activity Index (RADAI) were collected. Primary outcome was DMARD implementation adherence operationalised as the difference in proportion of non-adherent participants (<80% taking adherence) between intervention and control group after 3 months using a Chi-squared test. Two sample t-tests and Wilcoxon rank-sum test were performed to test for differences on secondary outcomes.Results Of the 110 intervention participants that started the study, 87 participants (79%) installed the game and had a median playtime of 9.7 hours at 3 months. Overall, 186 participants completed the study. Adherence in intervention group (63%) and control group (54%) did not differ significantly (p=0.13) at 3 months. Neither were there differences oberved in CQR continuous score, beliefs about medication (BMQ) or clinical outcomes (HAQ and RADAI).Conclusion A serious game aimed at reinterpreting attitudes toward medication failed to show an effect on adherence to DMARDs or clinical outcomes in patients with RA. The game was played frequently indicating that it can be an effective channel for reaching patients.Trial registration number NL7217.
first_indexed 2024-04-11T14:30:26Z
format Article
id doaj.art-f810a76e7f784bb593b4ae78dbdf0cfb
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-04-11T14:30:26Z
publishDate 2022-11-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-f810a76e7f784bb593b4ae78dbdf0cfb2022-12-22T04:18:39ZengBMJ Publishing GroupRMD Open2056-59332022-11-018210.1136/rmdopen-2022-002616Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trialSandra van Dulmen0Johanna E Vriezekolk1Bart van den Bemt2Harald E Vonkeman3Renske CF Hebing4Bart P H Pouls5Charlotte L Bekker6Fatma Gundogan7Hein AW van Onzenoort8Liesbeth I van de Ven9Rob Tieben10Netherlands Institute for Health Services Research, NIVEL, Utrecht, The NetherlandsRheumatology, Sint Maartenskliniek, Nijmegen, the NetherlandsPharmacy, Sint Maartenskliniek Afdeling Reumatologie, Nijmegen, The NetherlandsDepartment of Rheumatology & Clinical Immunology, Medisch Spectrum Twente, Enschede, The NetherlandsRheumatology, Pharmacy, Reade Hoofdlocatie Dr Jan van Breemenstraat, Amsterdam, The Netherlands1 Research & Innovation, Sint Maartenskliniek, Ubbergen, Gelderland, The Netherlands2 Department of Pharmacy Radboudumc, Radboud Institute for Health Sciences, Nijmegen, Gelderland, The Netherlands3 Pharmacy, Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Gelderland, The Netherlands2 Department of Pharmacy Radboudumc, Radboud Institute for Health Sciences, Nijmegen, Gelderland, The Netherlands6 Pharmacy, Maastricht UMC+, Maastricht, Limburg, The Netherlands9 Research, Development and Innovation, Game Solutions Lab, Eindhoven, The NetherlandsObjective To examine the effect on adherence to disease modifying anti-rheumatic drugs (DMARDs) in participants with rheumatoid arthritis (RA) of a serious game that targeted implicit attitudes toward medication.Methods A multicentre randomised controlled trial (RCT) was performed with adults with RA that used DMARDs and possessed a smartphone/tablet. Control and intervention groups received care as usual. The intervention group played the serious game at will during 3 months. Game play data and online questionnaires Compliance Questionnaire on Rheumatology (CQR), Beliefs about Medicine Questionnaire (BMQ), Health Assessment Questionnaire (HAQ) and Rheumatoid Arthritis Disease Activity Index (RADAI) were collected. Primary outcome was DMARD implementation adherence operationalised as the difference in proportion of non-adherent participants (<80% taking adherence) between intervention and control group after 3 months using a Chi-squared test. Two sample t-tests and Wilcoxon rank-sum test were performed to test for differences on secondary outcomes.Results Of the 110 intervention participants that started the study, 87 participants (79%) installed the game and had a median playtime of 9.7 hours at 3 months. Overall, 186 participants completed the study. Adherence in intervention group (63%) and control group (54%) did not differ significantly (p=0.13) at 3 months. Neither were there differences oberved in CQR continuous score, beliefs about medication (BMQ) or clinical outcomes (HAQ and RADAI).Conclusion A serious game aimed at reinterpreting attitudes toward medication failed to show an effect on adherence to DMARDs or clinical outcomes in patients with RA. The game was played frequently indicating that it can be an effective channel for reaching patients.Trial registration number NL7217.https://rmdopen.bmj.com/content/8/2/e002616.full
spellingShingle Sandra van Dulmen
Johanna E Vriezekolk
Bart van den Bemt
Harald E Vonkeman
Renske CF Hebing
Bart P H Pouls
Charlotte L Bekker
Fatma Gundogan
Hein AW van Onzenoort
Liesbeth I van de Ven
Rob Tieben
Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
RMD Open
title Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
title_full Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
title_fullStr Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
title_full_unstemmed Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
title_short Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial
title_sort gaming for adherence to medication using ehealth in rheumatoid arthritis gamer study a randomised controlled trial
url https://rmdopen.bmj.com/content/8/2/e002616.full
work_keys_str_mv AT sandravandulmen gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT johannaevriezekolk gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT bartvandenbemt gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT haraldevonkeman gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT renskecfhebing gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT bartphpouls gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT charlottelbekker gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT fatmagundogan gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT heinawvanonzenoort gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT liesbethivandeven gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial
AT robtieben gamingforadherencetomedicationusingehealthinrheumatoidarthritisgamerstudyarandomisedcontrolledtrial